Platinum‐based chemotherapy for early triple‐negative breast cancer

BACKGROUND: Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with shorter survival and a higher likelihood of the cancer returning. In early TNBC, platinum‐based chemotherapy has been shown to improve pathological complete response (pCR); however, its effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Sofia RE, Willson, Melina L, Egger, Sam J, Beith, Jane, Dear, Rachel F, Goodwin, Annabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486188/
https://www.ncbi.nlm.nih.gov/pubmed/37681577
http://dx.doi.org/10.1002/14651858.CD014805.pub2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486188/
https://www.ncbi.nlm.nih.gov/pubmed/37681577
http://dx.doi.org/10.1002/14651858.CD014805.pub2

Ejemplares similares